//
Update in the Percutaneous Management of Coronary Chronic Total Occlusions
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up
Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status